Moderna Has Chance to Be ‘Vaccine of Choice’: Johns Hopkins

Bloomberg Breaking News Business Yahoo

Moderna Has Chance to Be ‘Vaccine of Choice’: Johns Hopkins,

Nov.17 — Johns Hopkins Center for Health Security Senior Scholar Dr. Amesh Adalja discusses vaccine options from Moderna Inc. and Pfizer Inc. and rising hospitalizations in the U.S. He speaks with Bloomberg’s Francine Lacqua on "Bloomberg Surveillance." The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and majority owner of Bloomberg LP, the parent company of Bloomberg News., ,

About the author: Bob S
Tell us something about yourself.
Prepper Homes and Survival
Bob S avatar